DLin-MC3-DMA
化学名称
[(6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl] 4-(dimethylamino)butanoate
DLin-MC3-DMA•LNP
Structure: 
产品编号
CH51003
CAS
1224606-06-7
分子式
C43H79NO2
分子量
642.09
规格标准
| Catalog No. | CH51003 |
| CAS No. | 1224606-06-7 |
| Molecular Formula | C43H79NO2 |
| Molecular Weight | 642.09 |
品类工艺支持
CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.
概况
DLin-MC3-DMA (also known as [(6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl] 4-(dimethylamino)butanoate) (CAS 1224606-06-7, MF C43H79NO2, MW 642.09) is an ionizable lipid analog studied in lipid nanoparticle (LNP) formulations for nucleic acid delivery research, including mRNA and siRNA platforms. Practical chemistry topics around this compound include head-group structure, ester or amine linker chemistry, and tail unsaturation. Project scale-up and custom synthesis are coordinated by the CHEMOS R&D team across laboratory and production sites.
应用
- DLin-MC3-DMA (1224606-06-7) supply and analog preparation for research programs
- Lipid nanoparticle (LNP) formulation research for mRNA / siRNA delivery
- Ionizable lipid library and head-group / tail analog screening
- Process-development support for scalable ionizable lipid preparation